| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 03/08/2007 | CA2620085A1 Isoindole-imide compounds and compositions comprising and methods of using the same |
| 03/08/2007 | CA2619919A1 Diaminopyrimidines as p2x3 and p2x2/3 modulators |
| 03/08/2007 | CA2619912A1 Novel cycloalkane carboxamides as factor xa inhibitors |
| 03/08/2007 | CA2619448A1 6-arylalkylamino- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 03/08/2007 | CA2606106A1 Heterocyclic anti-viral compounds comprising metabolizable moieties and their uses |
| 03/08/2007 | CA2604551A1 Jak kinase inhibitors and their uses |
| 03/07/2007 | EP1760081A1 Method for the production of pyrrolidine-1,2-dicarboxylic acid-1-(phenyl(-amide))-2-(phenyl(-amide)) derivatives and 1-(phenylcarbamoyl)-pyrrolidine-2-carboxylic acid derivatives as intermediate products |
| 03/07/2007 | EP1760079A1 Compounds as cor5 antagonists |
| 03/07/2007 | EP1758921A2 Compounds for proteasome enzyme inhibition |
| 03/07/2007 | EP1758897A1 Novel diazine derivatives, their manufacture and use as pharmaceutical agents |
| 03/07/2007 | EP1758896A1 Pyridinyl-isoxazoles and their use as herbicides |
| 03/07/2007 | EP1758895A1 Gonadotropin releasing hormone receptor antagonists |
| 03/07/2007 | EP1758891A2 Benzimidazolone carboxylic acid derivatives |
| 03/07/2007 | EP1758890A1 7-pyrazolylbenzazepines having affinity for d3 receptor |
| 03/07/2007 | EP1758883A1 Substituted 2-quinolyl-oxazoles useful as pde4 inhibitors |
| 03/07/2007 | EP1758873A1 Ubiquitin ligase inhibitors |
| 03/07/2007 | EP1758864A1 Substituted tetrahydro-2h-isoquinolin-1-one derivatives, method for the production thereof, and use of the same as medicaments |
| 03/07/2007 | EP1758862A1 Aminopyridine derivatives as selective dopamine d3 agonists |
| 03/07/2007 | EP1758860A1 Saturated and unsaturated 3-pyridyl-benzocycloalkylmethyl-amines for use in the treatment of pains, depressions and anxiety states |
| 03/07/2007 | EP1758857A1 Indole derivatives as antiviral agents |
| 03/07/2007 | EP1758585A2 Hiv integrase inhibitors |
| 03/07/2007 | EP1758578A2 Novel indazole carboxamides and their use |
| 03/07/2007 | EP0959076B1 Heteroarylperidines and piperazines and their use as antipsychotics and analgetics |
| 03/07/2007 | CN1926148A Beta-aminoacid-derivatives as factor Xa inhibitors |
| 03/07/2007 | CN1926137A Pyrrole-derivatives as factor Xa inhibitors |
| 03/07/2007 | CN1926136A Amino cyclopropane carboxamide derivatives as bradykinin antagonists |
| 03/07/2007 | CN1926135A Cycloalkyl derivatives of 3-hydroxy-4-pyridinones |
| 03/07/2007 | CN1926129A Novel insecticides |
| 03/07/2007 | CN1926127A Novel 2-heteroaryl-substituted benzimidazole derivative |
| 03/07/2007 | CN1926097A Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as FAAH enzyme inhibitors |
| 03/07/2007 | CN1925859A 4-(sulfanyl-pyrimidin-4-ylmethyl)-morpholine derivatives and related compounds as GABA receptor ligands for the treatment of anxiety, depression and epilepsy |
| 03/07/2007 | CN1923832A Novel pyridazinone compound, preparation method and application thereof |
| 03/07/2007 | CN1923812A New compounds |
| 03/07/2007 | CN1303081C Herbicidal 5-benzyloxymethyl-1,2,-isoxazoline derivs |
| 03/07/2007 | CN1303071C Substituted aminosalicylic acid amides with fungicidal effect and intermediate products for production thereof |
| 03/07/2007 | CN1303067C Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases |
| 03/07/2007 | CN1303066C 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 03/06/2007 | US7186844 Alkyl- or phenyl-substituted 2-oxazolidinones; reacting a dihalo compound with a primary amine and carbon dioxide; nontoxic; industrial scale |
| 03/06/2007 | US7186841 Antiinflammation agents |
| 03/06/2007 | US7186829 Aryl-substituted heterocyclic enaminones |
| 03/06/2007 | US7186827 Dipeptide synthesis |
| 03/06/2007 | US7186746 Indoles having anti-diabetic activity |
| 03/06/2007 | US7186743 drugs such as 1 -[4-(aminosulfonyl)phenyl]-8-{[(trifluoromethyl)sulfonyl]amino}-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide, used as antiinflammatory agents, antiarthritic agents, antipyretics or analgesics |
| 03/06/2007 | US7186738 antibiotics such as (5R)-3-[3-Fluoro-4-(3-methylisoxazol-5-yl)phenyl]-5-(1H-1,2,3-triazol-1-ylmethyl)-1,3-oxazolidin-2-one, having effective activity against both grampositive and gramnegative pathogens |
| 03/06/2007 | US7186734 Binding to antagonist or inverse antagonist as antiinflammatory agentsand immunological disorders |
| 03/06/2007 | US7186724 central nervous system disorders; psychological disorders; Parkinson's disease; Huntington's disease ; sleep disorders |
| 03/06/2007 | US7186718 For therapy of autoimmune, inflammatory, proliferative and hyperproliferative diseases and immunologically-mediated diseases including rejection of transplanted organs or tissues and Acquired Immunodeficiency Syndrome (AIDS |
| 03/06/2007 | US7186717 Pyrrolidine derivatives as Factor Xa inhibitors |
| 03/06/2007 | US7186710 PDE4/7 inhibitors useful in treatment of airway disorders, autoimmune system disorders, skin disorders, arthritis, nerve system disorders |
| 03/06/2007 | US7186709 Subjecting a vinyl ethers and an unsaturated ketoester to suitable conditions to generate a scaffold having the core dihydropyrancarboxamide or dihydropyrancarboxylic ester or acid; anticarcinogenic agents |
| 03/01/2007 | WO2007025247A2 Transglutaminase inhibitors and methods of use thereof |
| 03/01/2007 | WO2007024004A1 Phenylpyridone derivative |
| 03/01/2007 | WO2007023882A1 Derivative having ppar agonistic activity |
| 03/01/2007 | WO2007023507A2 Oxazolidinones bearing antimicrobial activity composition and methods of preparation |
| 03/01/2007 | WO2007023143A1 (indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid cb1 receptor |
| 03/01/2007 | WO2007023110A2 P38 map kinase inhibitors and methods for using the same |
| 03/01/2007 | WO2007022938A2 Compounds |
| 03/01/2007 | WO2007022936A1 Triazolyl derivatives of azabicyclo [3.1.0] hexane as dopamine d3 receptor modulators |
| 03/01/2007 | WO2007022933A1 Triazole derivatives as modulators of dopamine d3 receptors |
| 03/01/2007 | WO2007022638A1 Benzodiazepine and benzopiperazine analog inhibitors of histone deacetylase |
| 03/01/2007 | WO2007003961A3 Gpcr agonists |
| 03/01/2007 | WO2007002181A3 Tetrahydrocarbazole derivatives useful as androgen receptor modulators (sarm) |
| 03/01/2007 | WO2006138510B1 Substituted enaminones as nicotinic acetylcholine receptor modulators |
| 03/01/2007 | WO2006116157A9 Dipeptidyl peptidase-iv inhibitors |
| 03/01/2007 | WO2006036994A3 Modulators of crth2, cox-2 and faah |
| 03/01/2007 | WO2005117882A9 Hydroxamic acid derivatives as metalloprotease inhibitors |
| 03/01/2007 | US20070049751 5-(5-iodo-2-isopropyl-4-methoxy-phenoxy)-pyrimidine-2,4-diamine; using iodine monchloride for iodination, cyanoalkylation, hdyrogenation, cyclization; chemical intermediates; using guanidine carbonate, Brederick's reagent and aniline reagent |
| 03/01/2007 | US20070049611 Phosphodiesterase 4 inhibitors |
| 03/01/2007 | US20070049594 Novel compounds and compositions as cathepsin inhibitors |
| 03/01/2007 | US20070049592 Bis-aryl urea compounds and methods of use |
| 03/01/2007 | US20070049589 N-(4-{N'-[2-(6-Bromo-1H-indol-3-yl)-acetyl]-guanidinomethyl}-2,6-dichloro-phenyl)-acetamide, for example; useful in the treatment of neurological disorders related to beta-amyloid production, particularly, treatment of Alzheimer's Disease and similar diseases |
| 03/01/2007 | US20070049588 Atm inhibitor |
| 03/01/2007 | US20070049587 Factor Xa inhibitors |
| 03/01/2007 | US20070049584 Antiinflammatory agents, antidepressants, analgesics, purinergic receptor antagonists; neurodegenerative diseases, spinal cord injuries; 1-(2,3-dichlorophenyl)-N-[(2-methylphenyl)methyl]-1H-tetraazol-5-amine |
| 03/01/2007 | US20070049583 Benzoxazine and benzothiazine derivatives and their use in pharmaceutical agents |
| 03/01/2007 | US20070049582 Substituted-3-indolyl-4-piperidino-alkyl heterocycles for the treatment of depression |
| 03/01/2007 | US20070049577 CGRP antagonists |
| 03/01/2007 | US20070049573 Pyrrole-Derivatives as Factor Xa Inhibitors |
| 03/01/2007 | US20070049570 Quinoline derivatives as phosphodiesterase inhibitors |
| 03/01/2007 | US20070049558 New Spirotricyclic Derivatives and Their Use as Phosphodiesterase-7 Inhibitors |
| 03/01/2007 | US20070049495 1-Methyl, 3-trifluoromethyl,4-(2-(4-(tert-butylpyrazol-1-yl),2-cyano,1-tert-butylcarbonyloxy)ethylene)-pyrazole; agriculture; preventing the attachment of aquatic organisms to boats, construction materials, heat excangers; coolants; water supply systems; engineering plants; reservoirs; marine/underwater |
| 03/01/2007 | CA2621164A1 Derivative having ppar agonistic activity |
| 03/01/2007 | CA2620414A1 Benzodiazepine and benzopiperazine analog inhibitors of histone deacetylase |
| 03/01/2007 | CA2620254A1 P38 map kinase inhibitors and methods for using the same |
| 03/01/2007 | CA2620173A1 Alpha2c adrenoreceptor agonists |
| 03/01/2007 | CA2620052A1 Indenoisoquinolinone analogs and methods of use thereof |
| 03/01/2007 | CA2619770A1 Phenylpyridone derivative |
| 03/01/2007 | CA2619038A1 (indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid cb1 receptor |
| 02/28/2007 | EP1757602A1 Vla-4 inhibitor |
| 02/28/2007 | EP1757599A1 Indole derivatives having piperidine rings |
| 02/28/2007 | EP1757596A1 Tyrosine derivatives substituted by n-phenylacryloyl as agonists of hppar alpha and hppar gama |
| 02/28/2007 | EP1757591A1 Cinnamide compound |
| 02/28/2007 | EP1757292A1 Method of treating ocd and tic disorders |
| 02/28/2007 | EP1756106A1 Cyclohexylalanine derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 02/28/2007 | EP1756097A1 2-styryl-4-oxazole-methanol-ethers and their use as tyrosine kinase inhibitors |
| 02/28/2007 | EP1756096A1 Indolyl derivatives as liver-x-receptor modulators |
| 02/28/2007 | EP1756095A2 Cyanopyrrole containing cyclic carbamate and thiocarbamate biaryls and methods for preparing the same |
| 02/28/2007 | EP1756094A1 3-cycloalkylbenzazepines as histamine h3 antagonists |
| 02/28/2007 | EP1756091A1 Non nucleoside reverse transcriptase inhibitors |
| 02/28/2007 | EP1756089A1 Mercaptoimidazoles as ccr2 receptor antagonists |